Tuesday, July 17, 2007 8:49:48 PM
Re: "I don't believe we have any rights to PEG encapsulation beyond our assisting Novocell in its endeavors."
The conformal coating that Novocell is using in its current clinical trial is Surmodics. I don't know why Novocell talks as if it were their technology. The name of the coating technology, according to Surmodics, is "CELLabration". For further info, see http://www.surmodics.com/pdf/cellabration.pdf
Surmodics is currently seeking additional collaborations for the CELLabration technology. From the link above: "SurModics Regenerative Technologies seeks to partner with visionary medical device and biotechnology companies to commercialize this paradigm-changing technology for the delivery of treatments/therapies as yet not possible."
The conformal coating that Novocell is using in its current clinical trial is Surmodics. I don't know why Novocell talks as if it were their technology. The name of the coating technology, according to Surmodics, is "CELLabration". For further info, see http://www.surmodics.com/pdf/cellabration.pdf
Surmodics is currently seeking additional collaborations for the CELLabration technology. From the link above: "SurModics Regenerative Technologies seeks to partner with visionary medical device and biotechnology companies to commercialize this paradigm-changing technology for the delivery of treatments/therapies as yet not possible."
The obstacle to discovery is the illusion of knowledge.
Recent SRDX News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/21/2025 05:15:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:16:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:15:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:14:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:13:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:11:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:08:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:06:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:04:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 11:03:24 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 11/19/2025 09:48:05 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/19/2025 09:32:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 09:30:15 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 11/19/2025 02:47:33 PM
